Abstracts from the 10th European Breast Cancer Conference

At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Fatima Cardoso, MD, from the Champalimaud Clinical Center, Lisbon, Portugal, discusses abstracts presented at the conference, including results from the EPHOS-B trial, which was designed to evaluate lapatinib and trastuzumab, alone and in combination, for early HER2-positive breast cancer; and results from the EORTC 10085/TBCRC/BIG/NABG International Male Breast Cancer Program, which was designed to understand pathologic prognostic factors of male breast cancer.

Year of Production:
Running Time:
Color/Sound:

2016
3:06
Color/Sound

Comments are closed.